HbA1c as Screening Biomarker of Dyslipidemia in Type 2 Diabetes Mellitus Patients

International Journal of Advances in Medicine
doi 10.18203/2349-3933.ijam20183130
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medip Academy

Related search

Dyslipidemia Prevalence, Atherogenicity and Type 2 Diabetes Mellitus

Metabolism: Clinical and Experimental
EndocrinologyMetabolismDiabetes
2020English

Prevalence of Dyslipidemia in Patients With Type 2 Diabetes Mellitus: A Cross Sectional Study

Journal of Medical Science And clinical Research
2019English

Evaluation of 1, 5-Anhydroglucitolas a Salivary Biomarker in Type 2 Diabetes Mellitus Patients

Journal of Advanced Clinical and Research Insights
2019English

Configuration of Dyslipidemia in Patients With Type 2 Diabetes Mellitus Visiting Tertiary Care Hospital Quetta-Pakistan

Pure and Applied Biology
2018English

Effect of Participation in Type 2 Diabetes Mellitus (T2DM) Education Pathway on HbA1c

The Bangkok Medical Journal
2016English

Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes Mellitus

Archives of endocrinology and metabolism
EndocrinologyMetabolismDiabetes
2016English

Can Hba1c Be a Marker for Cardiovascular Risk in Type 2 Diabetes Mellitus

International Journal of Medical Research and Review
2015English

Blood Glucose Level and HbA1C in Pediatric Patients With Diabetes Mellitus Type 1

Althea Medical Journal
2017English

The Relationship Between Self Monitoring of Blood Glucose Frequency and HbA1c in Patients With Type 2 Diabetes Mellitus

The Medical Journal of Okmeydanı Training and Research Hospital
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy